MediMabBio
PrivateLast Round
Series B
Oct 24, 2025
Est. Valuation
$13.64M
Total Funding Raised
$38M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
MediMabBio is a biotechnology company that develops protein therapeutics, including therapeutic antibodies and fusion proteins, for the treatment of cancer and autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MediMabBio Comparables
Compare MediMabBio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Hummingbird Bioscience | 77% | |
| Synthekine | 76% | |
| Xencor, Inc. | 71% |
MediMabBio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Oct 24, 2025 | ||||
| Series A | Feb 1, 2021 | ||||
| Pre Seed | Feb 15, 2019 |
MediMabBio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Seoul Investment Partners | Series B |
| Hyundai Investment Partners | Series B |
| BNH INVESTMENT | Series A, Pre Seed, Series B |
| Smilegate Investment | Pre Seed, Series B, Series A |
| iM Investment Partners | Series B |
| KB Investment | Series B |
| Timefolio Asset Management | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 20, 2026
Monthly visitors increased 273% MoM, reaching 7.1K.
- Oct 24, 2025
$17M round led by Hyundai Investment Partners and Timefolio Asset Management.
MediMabBio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about MediMabBio's valuation, stock price, and market status.
Is MediMabBio a public or private company?
MediMabBio is a private company.
What is the current stock price of MediMabBio?
MediMabBio is a private company with no public stock price. No recent secondary market data is available.
How much is MediMabBio worth (valuation)?
Valuation information for MediMabBio is not publicly available.
Can I buy MediMabBio stock?
MediMabBio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was MediMabBio's last funding round?
Funding round information for MediMabBio is not publicly available.
Who are the main investors in MediMabBio?
Investor information for MediMabBio is not publicly disclosed.
Will MediMabBio IPO soon?
No public IPO plans have been announced for MediMabBio.
How can I track MediMabBio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor MediMabBio's secondary market activity and sign up for updates.